Skip to Main Content
Yale Public Health Magazine

Heart Medications Tied to Greater Heart Attack Risk

Yale Public Health: Fall 2022
2 Minute Read

For people with coronary heart disease, beta blockers can improve survival and quality of life, while aspirin and other antiplatelet medications can reduce the risk of a heart attack.

But those protections could backfire during hot weather, when heart attacks are more likely. A new study found that, among people suffering nonfatal heart attacks associated with hot weather, an outsize portion are taking these heart drugs.

The study appears online in Nature Cardiovascular Research.

“Patients taking these two medications have higher risk,” said Kai Chen, PhD, an assistant professor in the department of epidemiology (environmental health) at the Yale School of Public Health and first author of the study. “During heat waves, they should really take precautions.”

Using a registry, the authors looked at 2,494 cases in which individuals experienced a nonfatal heart attack in Augsburg, Germany, during hot months (May through September) between 2001 and 2014.

In previous research, they had shown that exposure to either heat or cold made heart attacks more likely, and they calculated that heat-related heart attack rates would rise once the planet has warmed by 2 to 3 degrees Celsius over preindustrial times.

The current study built on that research by examining patients’ medication use prior to their heart attack.

It turned out that users of beta blockers or antiplatelet medications were likelier to have heart attacks during the hottest days compared with other days. Antiplatelet medication use was associated with a 63% increase in risk, and beta blockers with a 65% increase. People taking both drugs had a 75% higher risk. Nonusers of those medications were not more likely to have a heart attack on hot days.

The study doesn’t prove that these medications caused the heart attacks, nor that they make people more vulnerable to heart attack. Although it’s possible that they did increase the risk of heart attacks triggered by hot weather, it’s also possible that patients’ underlying heart disease explains both the prescriptions and the higher susceptibility to heart attack during hot weather.

Still, there is at least one clue that these two medication types may render people more vulnerable: For the most part, other heart medications didn’t show a connection to heat-related heart attacks. (An exception was statins. When taken by younger people, statins were associated with an over threefold risk of a heart attack on hot days.)

“We hypothesize that some of the medications may make it hard to regulate body temperature,” Chen said. He plans to try to untangle these relationships in future studies.

Article outro

Author

Jerry Blair
Previous Article
Climate Change Report Showcases Benefits of Interdisciplinary Collaboration
Next Article
Voices: Quotables from YSPH faculty in the news

Explore the Issue

Issue Contents

Features
Biomedical Data Science Program Accepts Four New Fellows
Humanitarian Research Lab Documenting Potential War Crimes in Ukraine
YSPH's Collaborative Culture
Multidisciplinary COPPER Center Brings a Public Health Lens to Cancer Care
Yale Institute for Global Health Brings Researchers Together to Improve World Health
Cross-Country Collaborators Monitor the Spread of COVID-19
YSPH Partners with Connecticut Department of Public Health on Workforce Training Programs
Global Health Justice Partnership Brings Students to the Front Lines of Public Health Policy, Practice, and Law
Dean’s Message
Dean’s Message from Melinda Pettigrew - Fall 2022
Advances
Proximity to Fracking Sites Associated with Risk of Childhood Cancer
Yale Study Identifies Causes of Cancers
Economic Burden of Lyme Disease Could Be Nearly $1 Billion Annually
As U.S. Launches New Crisis Hotline, Nearly Half of Counties Lack Response Teams
Climate Change Report Showcases Benefits of Interdisciplinary Collaboration
Heart Medications Tied to Greater Heart Attack Risk
Voices
Voices: Quotables from YSPH faculty in the news
Centers
Collaboration Drives Innovation
Stay Involved
Shiller Foundation Gift Expands Students’ Public Health Learning Experiences
Alumni
Paying it Forward
2022 Alumni News
In Memoriam
2022 In Memoriam
School Notes
Dreamer Girls Project Is a ‘Dream Come True’ For YSPH Professor
Melinda Pettigrew Begins Term as Interim Dean of YSPH
Global Health Leadership Initiative Targets Inequities in Sepsis Outcomes and Care
New Activist in Residence Program Targets Social Justice
Professor Linda Niccolai Appointed Associate Dean for Academic Affairs
Sten Vermund’s Tenure as Dean of YSPH Marked by Historic Gains… and COVID-19
Yale Biostatistician Heping Zhang Delivers Prestigious Neyman Lecture
Yale Superfund Research Center to Investigate Water Contaminants Linked to Cancer
Awards & Honors
Awards & Honors Fall 2022
Elm City Health
Community Impact Lab Brings Students and Community Workers Together to Improve Public Health
YSPH Around the World
Fall 2022: YSPH around the world

Explore More

Featured in this article